ABNORMAL tissue anitigenis have beeni demoiistrated by direct immuiioclhemicaf analysis in an umber of human tumours (McKenna, Sanderson and Blakemore, 1964; Tee, Wang and Watkins, 1964) as well as spontaneous (Abramoff, Chinchiniian and Saunders, 1959 ; Pontieri, Bianco and Plescia, 1962) and experimeintallv induced animal tumours (Brondz. 1964; Narcissov and Abelev, 1959) . The largest body of evidence however is that derived from investigations of carciniogen induced liver tumours. Hence abnormal microsomal antigens have beeni denioiistrated bv immuniodiffusion methods in both transplanted rat (Deckers. 1964; Maisin, 1964a) and mouse (Abelev, 1963) hepatomas originallv iinduced with carcinogenic aminoazo dyes, whilst Hirai, Taga, Isaka, Satoh and Warabioka (1963) have reported the presence of a soluble, tumour specific antigen in a rat ascites hepatoma. Pressman and co-workers (Hiramato, Jurand, Bernecky and Pressman, 1963) have also detected abnormal microsomal antigens in 2-acetamidofluorene induced rat liver tumours using immunofluorescence techniques and Tanigaki (1963) using this procedure showed the presence of abnormal cell surface antigens in a rat ascites hepatoma.
ABNORMAL tissue anitigenis have beeni demoiistrated by direct immuiioclhemicaf analysis in an umber of human tumours (McKenna, Sanderson and Blakemore, 1964; Tee, Wang and Watkins, 1964) as well as spontaneous (Abramoff, Chinchiniian and Saunders, 1959 ; Pontieri, Bianco and Plescia, 1962) and experimeintallv induced animal tumours (Brondz. 1964; Narcissov and Abelev, 1959) . The largest body of evidence however is that derived from investigations of carciniogen induced liver tumours. Hence abnormal microsomal antigens have beeni denioiistrated bv immuniodiffusion methods in both transplanted rat (Deckers. 1964; Maisin, 1964a) and mouse (Abelev, 1963) hepatomas originallv iinduced with carcinogenic aminoazo dyes, whilst Hirai, Taga, Isaka, Satoh and Warabioka (1963) have reported the presence of a soluble, tumour specific antigen in a rat ascites hepatoma. Pressman and co-workers (Hiramato, Jurand, Bernecky and Pressman, 1963) have also detected abnormal microsomal antigens in 2-acetamidofluorene induced rat liver tumours using immunofluorescence techniques and Tanigaki (1963) using this procedure showed the presence of abnormal cell surface antigens in a rat ascites hepatoma.
In assessing the significance of cell antigeni chaniges durinig aminioazo dye carcinogenesis in rat liver, the total changes, includinig both gain and loss, are being examined. These studies have revealed that a number of normal liver microsomal and soluble cytoplasmic protein (cell sap) antigenls are deleted from tumour (Baldwin, 1964) . In this communication evidence is presented indicatin-g that aminoazo dve induced tumours also conitaini abniormal antigens.
MATERIALS AND METHODS
.Ntormal rat liver
Normal liver was takeni from 3-4 month old male rats of an iinbred WN'istar straini maintained on a standard cubed diet (MR441B) with water ad libituin.
Amtinoazo dye induced liver tumours Liver tumours were induced bv feeding rats oni 4-dimethylaminoazobeiizenie (DMAB) at a level of 006 per cent in a low protein diet for 3 months and then on the basal diet alone for up to 2 months. Histological examination sho-ed that the tumours could be classified into two main tyTpes, bile duct carcinlomiia and hepatocellular carcinoma (Baldwin, 1964) .
In selecting tissue for anialysis, only well defined, noni-niecrotic tumour iiiasses were taken. These were removed following perfusion in situ with ice cold saline anid 0-44 al sucrose, care being taken to exclude gross contaminationi with liver.
CELL ANTIGENS OF DMAB TUMOOtURS
Some tumours were transplanted into syngeneic hosts in order to provide larger amounts of tumour tissue, and these grew in all cases. Againi only non-necrotic tumours were taken for study and generally, these were from the 2nd to 4th generation transplants.
Sub-cellular fractionation of tissue Sub-cellular fractions of liver or tumour were isolated usinig previously described methods (Baldwin, 1964) . Essentially, tissue samples, thoroughly perfused in situ with ice cold 0.15 M NaCl and 0 44 M sucrose, were homogenized in 0 44 Mr sucrose (1 to 2 ml./g. wet weight of tissue) and microsome fractions isolated from mitochondrial (20,000 g) supernatants by centrifugation at 105,000 g for 120 minutes. The microsome and supernatant (cell sap) fractions were then further purified by re-centrifugation at 105,000 g for 120 minutes. Unless used immediately, tihsue fractions were rapidly frozen in alcohol-solid CO2 mixture and stored at -20) C.
For immuiiochemical analysis, cell sap fractions were used directly without any further treatment, whilst microsomes were solubilized in 0-4 per cent sodium deoxycholate at pH 8X0 (Baldwin, 1964 Adult albino rabbits received intramuscular injections at .3 weekly intervals of tumour fractions (1 ml.) emulsified with an equal volume of Freund's adjuvant (complete) (Difco). In general, fractions from tumour were less effective than those from normal liver so that a more prolonged immunization course of 5 to x iiijections was necessary to produce sufficiently potent antisera.
Rabbits were bled 2 to 3 weeks after the final injection and sera collected. MIerthiolate was added to a concentration of 001 
RESULTS

Tumour cell sap antigens
Comparison of the agar gel immunodiffusion reaction patterns of normal liver (Ncs) and tumour (Tcs) cell sap fractions with anti-tumour antiserum (anti-Tcs) clearly demonstrates that two major tumour antigens do not cross-react with components in normal liver (Fig. 1, top pattern) . Furthermore, these abnormal tumour antigens do not cross-react with cell sap fractions prepared from apparently healthy liver taken from tumour-bearing rats ( Fig. 1 , lower pattern), thus demonstrating that they arise during tumour induction and not from a non-specific response during carcinogen administration.
Cell sap fractions from 18 individual DMAB-induced tumours have been examined and all preparations were found to contain antigens not cross-reacting with normal liver. Additionally abnormal tumour antigens were detectable in transplanted tumour. This is illustrated in Fig. 2 which shows the cross-reaction of cell sap fractions of two transplanted liver tumours (D8/4 and D20/1) and normal liver with an anti-tumour cell sap antiserum.
In order to confirm that the abnormal components observed in tumour were niot normal liver antigens present in greatly increased concentration, attempts were made to remove antibody reacting with these components by pre-absorptioi of anti-tumour cell sap antiserum with normal liver. Aliquots of antiserum were inicubated at 40 C. for 4 days with varying amounts of normal liver cell sap, and after removal of antigen-antibody precipitates by centrifugation (3000 r.p.m. 30 minutes), the absorbed sera were cross-reacted with normal liver and tumour cell sap fractions. As shown in Table I , absorption with normal liver cell sap at Immunoelectrophoresis of cell sap fractions further facilitated identificatioin of abnormal tumour antigens, at least seven components being detectable (Fig. 4) . The pattern obtained using antiserum exhaustivelyr absorbed with normal liver cell sap was not markedly different and at least five components detected followiNng reactioni with tumour cell sap did not cross-react with normal liver.
Tumour microsontal antiyens
In order to examine cha,nges in microsomal anitigens during IDMAB carciinogeniesis, rabbit antisera were prepared against whole microsome fractions isolatedl from pooled primary liver tumours. For immunodiffusion analysis, microsome fractions were solubilized in 04 per cent sodium deoxycholate and examined without any fiurther treatment. As shown previously (Baldwin, 1964) this procedure is without any great effect oIn microsomal antigens and permits examination of antigenic components in the solubilized protein fractioni.
The top pattern in Fig. 5 shows the agar-gel cross-reaction pattern of deoxycho'ate solubilized microsome fractions of normal liver (Nmic) and DMABinduced tumour (Tmic) with an anti-tumour microsome antiserum. Whilst the agar gel precipitation reactions were much weaker than those obtained with cell sap fractions, at least one tumour antigen not cross-reacting with normal liver was detected. Furthermore, as shown in the lower pattern, this tumour antigen did not cross-react with antigens in a microsome fraction prepared from apparentlv normal liver taken from a tumour-bearing rat after 5 months' DMAB feeding (NTLi.mic). This is interpreted as indicating that the abnormal tumour antigen (lid not arise as a result of some non-specific response during DMAB carcinogenesis.
Altogether 12 deoxycholate solubilized microsome preparations, each of which contained pooled tissue from 2 to 3 DMAB-induced tumours, have been examined and in each case, at least one tumour antigen not cross-reacting with normal liver was demonstrated. Abnormal microsomal antigen was also detected in two tumours induced with 3'methyl-DMAB as well as in transplanted tumour. This is illustrated in Fig. 6 which shows the agar gel cross-reaction pattern of solubilized microsome fractions of normal liver (Nmic) and a third generation transplant of a DMAB-induced tumour (D3mic) with anti-tumour microsome antiserum (antiTmic). In this case, two antigens in the transplanted tumour were shown not to cross-react with normal liver components.
Further confirmation of the presence of abnormal antigens in IDMAB-induced liver tumour was provided by the analysis of anti-tumour microsome antiserum l)re-absorbed with deoxycholate solubilized normal liver microsomes. Hence, pre-absorptioni at 40 C. for 4 days with 1*5 mg. normal liver microsomal protein/ml. anitiserum completely removed antibody reacting with this fraction. In contrast the abnormal precipitation line detected with tumour microsomes was not removed following absorption with up to 6 mg. liver microsomal protein/ml. antiserum.
Immunodiffusion patterns obtained using antiserum exhaustively absorbed with normal liver microsomes were also much simpler and, as shown in Fig. 7 Ncs Normal liver cell sap.
NTLics-Cell sap fraction of liver taken from tumour-bearing rat.
Tcs DMAB-induced liver tumour cell sap. All cell sap fractions contained 8-6 mg. protein/ml. Ii cipitation lines were also demonstrable following reaction of the tumour fraction with anti-normal liver microsome antiserum (anti-Nmic; centre reaction) further indicating that these lines are formed by antigens common to both normal liver and tumour. The centre reactions of microsome fractions with anti-normal liver microsome antiserum also demonstrate the concurrent loss of normal liver antigens from tumour.
Although the immunoelectrophoretic patterns obtained with anti-tumour microsome antisera exhaustively absorbed with normal liver microsomes were much weaker, abnormal tumour components were more easily detected, and as shown in Fig. 9 , four precipitation lines were formed following reaction with tumour microsomes whereas no reaction was detected with normal liver.
DISCUSSION
The present studies demonstrate that DMAB-induced rat liver tumours contain microsomal and cell sap antigens which are not detectable in normal liver. The absence of these antigens from liver taken from tumour-bearing rats also indicates that they arise during tumour induction and not as a non-specific response, such as cell population changes, during carcinogen feeding in the low protein diet. Furthermore, the finding that antibody reacting with the abnormal tumour microsome and cell sap antigens cannot be removed by exhaustive absorption of anti-tumour antiserum with normal liver fractions indicates that these antigens are not normal liver components present in greatly increased amounts. Thus for example, under the conditions used for pre-absorption of anti-tumour cell sap antiserum with normal liver, for the abnormal precipitation lines detected in tumour to be due to normal liver antigens, these components would need to be elevated at least 200-fold.
Abnormal microsomal antigens in transplanted rat hepatomas originally induced with DMAB have also been demonstrated using immunodiffusion methods by Maisin (1964) and Deckers (1964) . In these studies, the abnormal microsomal antigens were shown to be specific for each tumour line and there was no evidence of cross-reactivity with antigens in other primary or transplanted rat hepatomas. These results contrast with present findings where common microsomal antigens were demonstrated in primary tumours. This may be due to the use of antisera prepared against pooled microsome fractions from DMAB-induced liver tumours so that only common antigens would be detected whilst individual differences were obscured. Additionally, however, the tumours used by Maisin and Deckers had undergone repeated transplantation and this may have resulted in some antigenic simplification. In current studies (Baldwin and Barker, 1964) using antisera prepared against microsome fractions from two transplanted liver tumours it has been shown that each tumour possesses specific, non-cross-reacting antigens. In addition there were, however, common microsomal antigens not detectable in normal liver.
Previous studies on cell antigen changes during liver carcinogenesis have been restricted almost exclusively to microsomal antigens and little attention has been paid to antigens in other sub-cellular fractions. The present studies indicate that significant changes also occur in the soluble cytoplasmic protein fraction and a number of tumour antigens not detectable in normal or DMAB-treated rat liver were demonstrated. These findings are comparable with recent studies demon-899 strating abnormal soluble antigens in human tumours (Itakura, 1963; McKenna, Sanderson and Blakemore, 1964; Tee, Wang and Watkins, 1964) Further, more unequivocal evidence that DMAB-induced liver tumours contain tumour-specific antigens has been provided by the demonstration of induced immunity against tumours transplanted into syngeneic recipients (Baldwin and Barker, 1964 (Baldwin, 1962) . These antigens also reacted with rabbit antisera prepared against synthetic bovine serum albumin-DMAB conjugates (Baldwin, Beswick, Chayen and Cunningham, 1960) , indicating the presence of aminoazo dye prosthetic groups and this suggests that they are normal liver proteins modified as a result of covalent binding with DMAB metabolites. There is no evidence, however, that these antigens bear any relationship to the abnormal tumour components and it has been shown that there is little or no bound carcinogen in tumour (Miller and Miller, 1953 Korosteleva (1957) who demonstrated abnormal antigens in liver from o-aminoazotoluene treated mice which showed some reactivity to the carcinogen, whilst these antigens were absent from induced tumour.
A more attractive postulate is that tumour antigens arise through the specific action of DMAB on some self-reproducing template since this could alko explain the loss of normal liver cell sap and microsomal antigens from the emergent tumour (Baldwin, 1964) . As The present studies indicate that DMAB-induced liver tumours contain abnormal cell antigens and it has been shown also (Baldwin, 1963) that at least some of these antigens are present in the serum from tumour-bearing rats. These antigens are probably released following cell damage during carcinogen feeding and so should be available for the induction of an immune response in the host. Although recent studies (Baldwin and Barker, 1964) have shown that immunity can be induced against these tumours when transplanted into suitably pre-treated isogeneic hosts, no evidence has yet been obtained of any immune mechanisms operating during DMAB carcinogenesis. Nor, so far, has it been possible to demonstrate circulating anti-tumour antibody at any stage of carcinogen feeding. However, Maisin (1964b) has reported that immunization with rat hepatoma microsomes conferred some resistance to the carcinogenic action of DMAB.
Since it has been shown (Baldwin, unpublished observations) that cell bound antibody is involved in immunity to transplanted rat liver tumours, the possibility that this type of immune response develops in the rat during DMAB carcinogenesis is now being investigated.
SUMMARY
Aminoazo-dye-induced rat liver tumours have been shown to contain a number of common microsomal and cell sap antigens which were not detectable in normal liver. The absence of these antigens from DMAB-treated liver taken from tumourbearing rats demonstrated that they arose during tumour induction and not as a result of a non-specific response during carcinogen feeding. Absorption studies also indicated that they were not normal liver antigens present in tumour in greatly increased concentration.
The significance of the tumour antigens in aminoazo dye carcinogenesis is discussed together with the previous findings of antigen deletion. Furthermore, the possibility is considered that an immune response may be evoked against these antigens during DMAB carcinogenesis.
Thanks are due to Mrs. M. E. Marshall for skilled technical assistance. This work was supported by a block grant from the British Empire Cancer Campaign for Research.
